OUR PRODUCTS

MOBILE APPS

GENERAL INFO

LEXX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Lexaria Bioscience (LEXX) Earnings Date & Reports

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LEXX is expected to report earnings to fall 26.19% to -15 cents per share on October 29

Lexaria Bioscience LEXX Stock Earnings Reports

Q3'25

Est.

$-0.16

Q2'25

Missed

by $0.05

Q1'25

Est.

$-0.17

Q4'24

Missed

by $0.08

Q3'24

Missed

by $0.02

The last earnings report on July 18 showed earnings per share of -20 cents, missing the estimate of -15 cents. With 152.10K shares outstanding, the current market capitalization sits at 15.51M.

View a ticker or compare two or three

Compare

LEXX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LEXX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LEXX showed earnings on July 18, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

740 McCurdy Road

Phone

+1 250 765-6424

Employees

Web

https://www.lexariabioscience.com